The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retroperitoneal soft tissue sarcoma (RPS): Recent outcome improvement and refinement of treatment strategies at a single institution.
 
Marco Fiore
No Relationships to Disclose
 
Max Almond
No Relationships to Disclose
 
Francesco Barretta
No Relationships to Disclose
 
Dario Callegaro
No Relationships to Disclose
 
Chiara Colombo
No Relationships to Disclose
 
Stefano Radaelli
No Relationships to Disclose
 
Sandro Pasquali
No Relationships to Disclose
 
Marta Barisella
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Roberta Sanfilippo
No Relationships to Disclose
 
Claudia Sangalli
No Relationships to Disclose
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Rosalba Miceli
No Relationships to Disclose
 
Paolo Giovanni Casali
Honoraria - Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - ARIAD/Merck; Bayer; Blueprint Medicines; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MolMed (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Alessandro Gronchi
Honoraria - Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar